Unknown NA INTERVENTIONAL 3-arm NCT02526914

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

Sponsor: David Mankuta

Conditions Healthy

Interventions Intranasal Oxytocin Intranasal placebo Intranasal vasopressin

Updated 6 times since 2017 Last updated: Aug 16, 2015 Started: Oct 31, 2015 Primary completion: Jul 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02526914, this NA trial focuses on Healthy and remains ongoing. Sponsored by David Mankuta, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Oct 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Oct 2017 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

David Mankuta
Hebrew University of Jerusalem

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel